Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort

Abstract

CLIA was considered as a better platform for aPL detection in APS diagnosis. A combination of other detection platforms could assist in differential diagnosis as well as in identifying high-risk patients.